Skip to search formSkip to main contentSkip to account menu

anacetrapib

A cholesteryl ester transfer protein (CETP) inhibitor with hypocholesterolemic properties. Anacetrapib reduces the transfer of cholesteryl ester from… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Anticholesteremic AgentsOxazolidinones
MK 0859

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease
Highly Cited
2017
Highly Cited
2017
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
BACKGROUND Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin… 
Review
2014
Review
2014
Recent advances in pharmacotherapy for hypertriglyceridemia.
Highly Cited
2014
Highly Cited
2014
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
The present study is the first intervention study in a well-established, translational mouse model for hyperlipidaemia and… 
Highly Cited
2011
Highly Cited
2011
Preparative scale synthesis of the biaryl core of anacetrapib via a ruthenium-catalyzed direct arylation reaction: unexpected effect of solvent impurity on the arylation reaction.
In this report, we disclose our findings regarding the remarkable effect of a low-level impurity found in the solvent used for a… 
Highly Cited
2010
Highly Cited
2010
Safety of anacetrapib in patients with or at high risk for coronary heart disease.
BACKGROUND Anacetrapib is a cholesteryl ester transfer protein inhibitor that raises high-density lipoprotein (HDL) cholesterol… 
Highly Cited
2010
Highly Cited
2010
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
Objective—To examine the effects of treatments with niacin or anacetrapib (an inhibitor of cholesteryl ester transfer protein) on… 
Highly Cited
2009
Highly Cited
2009
Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors
Systematic identification of protein-drug interaction networks is crucial to correlate complex modes of drug action to clinical… 
Highly Cited
2008
Highly Cited
2008
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
Inhibition of cholesteryl ester transfer protein (CETP) with torcetrapib in humans increases plasma high density lipoprotein (HDL… 
Highly Cited
2008
Highly Cited
2008
Multiple‐Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects
Cholesteryl ester transfer protein (CETP) is a plasma protein that catalyzes the heteroexchange of cholesteryl esters from high… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)